These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effects of sildenafil on ventricular and vascular function in heart failure with preserved ejection fraction. Borlaug BA; Lewis GD; McNulty SE; Semigran MJ; LeWinter M; Chen H; Lin G; Deswal A; Margulies KB; Redfield MM Circ Heart Fail; 2015 May; 8(3):533-41. PubMed ID: 25782985 [TBL] [Abstract][Full Text] [Related]
5. Isosorbide Dinitrate, With or Without Hydralazine, Does Not Reduce Wave Reflections, Left Ventricular Hypertrophy, or Myocardial Fibrosis in Patients With Heart Failure With Preserved Ejection Fraction. Zamani P; Akers S; Soto-Calderon H; Beraun M; Koppula MR; Varakantam S; Rawat D; Shiva-Kumar P; Haines PG; Chittams J; Townsend RR; Witschey WR; Segers P; Chirinos JA J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28219917 [TBL] [Abstract][Full Text] [Related]
6. Left ventricular responses to acute changes in late systolic pressure augmentation in older adults. Sweitzer NK; Hetzel SJ; Skalski J; Velez M; Eggleston K; Mitchell GF Am J Hypertens; 2013 Jul; 26(7):866-71. PubMed ID: 23537892 [TBL] [Abstract][Full Text] [Related]
7. Effect of sildenafil on cardiac performance in patients with heart failure. Hirata K; Adji A; Vlachopoulos C; O'Rourke MF Am J Cardiol; 2005 Nov; 96(10):1436-40. PubMed ID: 16275194 [TBL] [Abstract][Full Text] [Related]
8. Treatment of pulmonary hypertension with left heart disease: a concise review. Desai A; Desouza SA Vasc Health Risk Manag; 2017; 13():415-420. PubMed ID: 29158679 [TBL] [Abstract][Full Text] [Related]
9. Phosphodiesterase 5 inhibitor sildenafil in patients with heart failure with preserved ejection fraction and combined pre- and postcapillary pulmonary hypertension: a randomized open-label pilot study. Belyavskiy E; Ovchinnikov A; Potekhina A; Ageev F; Edelmann F BMC Cardiovasc Disord; 2020 Sep; 20(1):408. PubMed ID: 32912157 [TBL] [Abstract][Full Text] [Related]
10. Arterial Stiffening With Exercise in Patients With Heart Failure and Preserved Ejection Fraction. Reddy YNV; Andersen MJ; Obokata M; Koepp KE; Kane GC; Melenovsky V; Olson TP; Borlaug BA J Am Coll Cardiol; 2017 Jul; 70(2):136-148. PubMed ID: 28683960 [TBL] [Abstract][Full Text] [Related]
11. Arterioventricular coupling and ventricular efficiency after antihypertensive therapy: a noninvasive prospective study. Osranek M; Eisenach JH; Khandheria BK; Chandrasekaran K; Seward JB; Belohlavek M Hypertension; 2008 Feb; 51(2):275-81. PubMed ID: 18158354 [TBL] [Abstract][Full Text] [Related]
12. Relation of ventricular-vascular coupling to exercise capacity in ischemic cardiomyopathy: a cardiac multi-modality imaging study. Wong RC; Dumont CA; Austin BA; Kwon DH; Flamm SD; Thomas JD; Starling RC; Desai MY Int J Cardiovasc Imaging; 2010 Feb; 26(2):151-9. PubMed ID: 19823943 [TBL] [Abstract][Full Text] [Related]
13. Effect of inorganic nitrate on exercise capacity in heart failure with preserved ejection fraction. Zamani P; Rawat D; Shiva-Kumar P; Geraci S; Bhuva R; Konda P; Doulias PT; Ischiropoulos H; Townsend RR; Margulies KB; Cappola TP; Poole DC; Chirinos JA Circulation; 2015 Jan; 131(4):371-80; discussion 380. PubMed ID: 25533966 [TBL] [Abstract][Full Text] [Related]
14. Resting ventricular-vascular function and exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study. Mohammed SF; Borlaug BA; McNulty S; Lewis GD; Lin G; Zakeri R; Semigran MJ; LeWinter M; Hernandez AF; Braunwald E; Redfield MM Circ Heart Fail; 2014 Jul; 7(4):580-9. PubMed ID: 24833648 [TBL] [Abstract][Full Text] [Related]
15. PDE 5 inhibition with udenafil improves left ventricular systolic/diastolic functions and exercise capacity in patients with chronic heart failure with reduced ejection fraction; A 12-week, randomized, double-blind, placebo-controlled trial. Kim KH; Kim HK; Hwang IC; Cho HJ; Je N; Kwon OM; Choi SJ; Lee SP; Kim YJ; Sohn DW Am Heart J; 2015 Jun; 169(6):813-822.e3. PubMed ID: 26027619 [TBL] [Abstract][Full Text] [Related]
16. Effects of fixed-dose isosorbide dinitrate/hydralazine on diastolic function and exercise capacity in hypertension-induced diastolic heart failure. Wilson RM; De Silva DS; Sato K; Izumiya Y; Sam F Hypertension; 2009 Sep; 54(3):583-90. PubMed ID: 19620510 [TBL] [Abstract][Full Text] [Related]
17. Effects of Cardiopulmonary Exercise Rehabilitation on Left Ventricular Mechanical Efficiency and Ventricular-Arterial Coupling in Patients With Systolic Heart Failure. Aslanger E; Assous B; Bihry N; Beauvais F; Logeart D; Cohen-Solal A J Am Heart Assoc; 2015 Oct; 4(10):e002084. PubMed ID: 26464425 [TBL] [Abstract][Full Text] [Related]
18. Long-term, dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure. Cicoira M; Zanolla L; Rossi A; Golia G; Franceschini L; Brighetti G; Marino P; Zardini P J Am Coll Cardiol; 2002 Jul; 40(2):304-10. PubMed ID: 12106936 [TBL] [Abstract][Full Text] [Related]
19. The β-Adrenergic Agonist Albuterol Improves Pulmonary Vascular Reserve in Heart Failure With Preserved Ejection Fraction. Reddy YNV; Obokata M; Koepp KE; Egbe AC; Wiley B; Borlaug BA Circ Res; 2019 Jan; 124(2):306-314. PubMed ID: 30582447 [TBL] [Abstract][Full Text] [Related]
20. A randomized pilot study on the effect of niacin on pulmonary arterial pressure. McNamara MJ; Sayanlar JJ; Dooley DJ; Srichai MB; Taylor AJ Trials; 2015 Nov; 16():530. PubMed ID: 26590128 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]